SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples quarterly earnings beat expectations, but the stock drew attention for selling off as traders focused on margin pressure from rising memory costs and weaker-than-expected China, iPad, and wearables results. The community is split between dip buyers citing strong iPhone demand and bears arguing that cautious growth and margin outlooks do not justify Apples high valuation.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs quarterly results beat expectations and raised guidance, with traders highlighting rapid AI-driven commercial growth and commercial revenue overtaking government revenue. Despite the strong report, the stock fell as many attributed the muted reaction to high valuation, elevated expectations and broader weakness in AI and technology shares, while bullish traders focused on the business momentum.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond offerings to fund its AI infrastructure buildout have fueled a sharp selloff, as traders focus on dilution, debt levels, and whether the spending will produce returns. Some say the financing was already outlined and could limit future raises, but concerns about leverage and execution dominate the discussion.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reaching its prespecified 80th death triggered final analysis, putting the GPS readout in acute myeloid leukemia at the center of discussion. Traders are split over the sharp decline since the milestone, attributing it to profit-taking and pre-readout risk reduction or speculating about a negative leak, though the results remain unknown.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs steep selloff ahead of its quarterly results is driving debate over whether strong results and guidance can overcome weakness across semiconductors following Intels disappointing report. Traders are split between expecting a rebound on evidence of AI and data-center demand and fearing another post-earnings decline amid high valuation concerns and recent tech-sector selling.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehrs quarterly earnings beat expectations and its fiscal 2027 revenue outlook was raised, reinforcing the bull case around demand for its AI chip burn-in testing systems. Traders praised the results and growth prospects, but debated why shares were falling despite the report, citing weak market sentiment, valuation concerns, and possible sell-the-news pressure.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblazes better-than-expected quarterly results and raised sales outlook, supported by accelerating B2 cloud-storage growth, are driving attention. Bulls see AI-related storage demand as a tailwind, while others point to the stocks sharp swings and fading post-earnings gains as reasons for caution.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Golds sharp selloff and repeated support breaks dominate the discussion, with traders citing shifting expectations for Fed rate hikes and forced liquidations as possible pressures. The community is split between seeing more downside and buying the dip, while questioning why gold has not acted as a safe haven amid market and geopolitical stress.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure amid a broad tech and AI-trade selloff, as traders question whether heavy data-center spending and borrowing will generate sufficient returns; Apples results failed to provide the market support some investors expected. The conversation is split between fears of a deeper correction and dip buyers looking for a rebound after the sharp decline.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs upcoming decision on deramiocel for Duchenne muscular dystrophy, with traders reading renewed commercial hiring and a broader perception of FDA flexibility as possible signs of approval. The hiring is not proof of an outcome, and the community remains divided between hopes for a narrow upper-limb approval and concerns about a rejection or further requirements given the advisory panels doubts about efficacy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
